Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.
Leal LF, de Paula FE, De Marchi P, de Souza Viana L, Pinto GDJ, Carlos CD, Berardinelli GN, Miziara JE, da Silva CM, Silva ECA, Pereira R, de Oliveira MA, Scapulatempo-Neto C, Reis RM. Leal LF, et al. Among authors: miziara je. Sci Rep. 2019 Mar 1;9(1):3209. doi: 10.1038/s41598-019-39965-x. Sci Rep. 2019. PMID: 30824880 Free PMC article.
Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.
Cavagna R, Escremim de Paula F, Sant'Anna D, Santana I, da Silva VD, da Silva ECA, Bacchi CE, Miziara JE, Dias JM, De Marchi P, Leal LF, Reis RM. Cavagna R, et al. Among authors: miziara je. JCO Glob Oncol. 2021 Apr;7:639-645. doi: 10.1200/GO.20.00615. JCO Glob Oncol. 2021. PMID: 33956502 Free PMC article. No abstract available.
Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.
Chiarantano RS, Vazquez FL, Franco A, Ferreira LC, Cristina da Costa M, Talarico T, Oliveira ÂN, Miziara JE, Mauad EC, Caetano da Silva E, Ventura LM, Junior RH, Leal LF, Reis RM. Chiarantano RS, et al. Among authors: miziara je. Cancer Control. 2022 Jan-Dec;29:10732748221121385. doi: 10.1177/10732748221121385. Cancer Control. 2022. PMID: 36204992 Free PMC article.
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
Cavagna RO, Pinto IA, Escremim de Paula F, Berardinelli GN, Sant'Anna D, Santana I, da Silva VD, Da Silva ECA, Miziara JE, Mourão Dias J, Antoniazzi A, Jacinto A, De Marchi P, Molina-Vila MA, Ferro Leal L, Reis RM. Cavagna RO, et al. Among authors: miziara je. Pathobiology. 2023;90(5):344-355. doi: 10.1159/000530587. Epub 2023 Apr 8. Pathobiology. 2023. PMID: 37031678
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.
Cavagna RO, Escremim de Paula F, Berardinelli GN, Bonatelli M, Santana I, Albino da Silva EC, Teixeira GR, Zaniolo BG, Mourão Dias J, Ferreira da Silva FA, Baston Silva CE, Guimarães MGB, Barone CP, Jacinto AA, Noleto da Nóbrega Oliveira RE, Miziara JE, De Marchi P, Molina-Vila MA, Leal LF, Reis RM. Cavagna RO, et al. Among authors: miziara je. Oncologist. 2024 Oct 3;29(10):e1419-e1424. doi: 10.1093/oncolo/oyae129. Oncologist. 2024. PMID: 38944844 Free PMC article.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G Jr, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JE, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA; INSPIRE investigators. Paz-Ares L, et al. Among authors: miziara je. Lancet Oncol. 2015 Mar;16(3):328-37. doi: 10.1016/S1470-2045(15)70046-X. Epub 2015 Feb 18. Lancet Oncol. 2015. PMID: 25701171 Free article. Clinical Trial.
Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.
Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A, Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JE, Papai ZS, Karaseva N, Thongprasert S, Portulas ED, von Pawel J, Zhang K, Selaru P, Tye L, Chao RC, Govindan R. Scagliotti GV, et al. Among authors: miziara je. J Clin Oncol. 2012 Jun 10;30(17):2070-8. doi: 10.1200/JCO.2011.39.2993. Epub 2012 May 7. J Clin Oncol. 2012. PMID: 22564989 Clinical Trial.
19 results